Cefuroxime axetil
Ceftin (cefuroxime axetil) is a small molecule pharmaceutical. Cefuroxime axetil was first approved as Ceftin on 1987-12-28. It is used to treat bacterial infections, bacterial meningitis, bacterial pneumonia, escherichia coli infections, and gonorrhea amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
infections | D007239 |
musculoskeletal diseases | D009140 |
stomatognathic diseases | D009057 |
respiratory tract diseases | D012140 |
otorhinolaryngologic diseases | D010038 |
nervous system diseases | D009422 |
urogenital diseases | D000091642 |
skin and connective tissue diseases | D017437 |
signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
cefuroxime axetil | ANDA | 2023-06-07 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
bacterial infections | — | D001424 | A49 |
bacterial meningitis | EFO_1000831 | D016920 | G00 |
bacterial pneumonia | EFO_1001272 | D018410 | J15.9 |
escherichia coli infections | EFO_1001318 | D004927 | B96.20 |
gonorrhea | DOID_7551 | D006069 | A54 |
haemophilus infections | EFO_1001127 | D006192 | — |
impetigo | EFO_1000714 | D007169 | L01 |
infectious bone diseases | — | D001850 | — |
klebsiella infections | EFO_1001353 | D007710 | — |
lyme disease | — | D008193 | A69.2 |
Show 6 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
13 clinical trials
View more details

Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | 9 | — | — | — | 4 | 13 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | CEFUROXIME AXETIL |
INN | — |
Description | Cefuroxime axetil is a cephalosporin. |
Classification | Small molecule |
Drug class | cephalosporins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)OC(C)OC(C)=O)=C(COC(N)=O)CS[C@H]12)c1ccco1 |
Identifiers
PDB | — |
CAS-ID | 64544-07-6 |
RxCUI | 20493 |
ChEMBL ID | CHEMBL1095930 |
ChEBI ID | 3516 |
PubChem CID | 6321416 |
DrugBank | — |
UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:

Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,431 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions

Mock data
Subscribe for the real data
Subscribe for the real data
498 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more